nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—Lisinopril—systemic scleroderma	0.328	1	CrCtD
Ramipril—ACE—systemic scleroderma	0.171	1	CbGaD
Ramipril—ACE—Lisinopril—systemic scleroderma	0.0787	0.408	CbGbCtD
Ramipril—ACE—Captopril—systemic scleroderma	0.0589	0.306	CbGbCtD
Ramipril—Enalapril—Captopril—systemic scleroderma	0.0535	0.226	CrCrCtD
Ramipril—SLC15A1—Lisinopril—systemic scleroderma	0.0316	0.164	CbGbCtD
Ramipril—Fosinopril—Lisinopril—systemic scleroderma	0.029	0.122	CrCrCtD
Ramipril—SLC15A1—Captopril—systemic scleroderma	0.0236	0.123	CbGbCtD
Ramipril—Moexipril—Lisinopril—systemic scleroderma	0.0218	0.0919	CrCrCtD
Ramipril—Spirapril—Lisinopril—systemic scleroderma	0.0188	0.0794	CrCrCtD
Ramipril—Cilazapril—Lisinopril—systemic scleroderma	0.0188	0.0794	CrCrCtD
Ramipril—Enalapril—Lisinopril—systemic scleroderma	0.0177	0.0745	CrCrCtD
Ramipril—Trandolapril—Lisinopril—systemic scleroderma	0.0177	0.0745	CrCrCtD
Ramipril—Nateglinide—Lisinopril—systemic scleroderma	0.0157	0.0664	CrCrCtD
Ramipril—Aspartame—Lisinopril—systemic scleroderma	0.015	0.0631	CrCrCtD
Ramipril—Quinapril—Lisinopril—systemic scleroderma	0.015	0.0631	CrCrCtD
Ramipril—Benazepril—Lisinopril—systemic scleroderma	0.0142	0.0601	CrCrCtD
Ramipril—ACE—forelimb zeugopod—systemic scleroderma	0.00346	0.226	CbGeAlD
Ramipril—ACE—pulmonary artery—systemic scleroderma	0.00259	0.169	CbGeAlD
Ramipril—ACE—skeletal joint—systemic scleroderma	0.00229	0.15	CbGeAlD
Ramipril—ACE—umbilical vein—systemic scleroderma	0.00171	0.112	CbGeAlD
Ramipril—ACE—artery—systemic scleroderma	0.00096	0.0628	CbGeAlD
Ramipril—ACE—endothelium—systemic scleroderma	0.000811	0.053	CbGeAlD
Ramipril—ACE—blood vessel—systemic scleroderma	0.000748	0.0489	CbGeAlD
Ramipril—SLC15A1—digestive system—systemic scleroderma	0.000386	0.0253	CbGeAlD
Ramipril—ACE—connective tissue—systemic scleroderma	0.000383	0.0251	CbGeAlD
Ramipril—ACE—smooth muscle tissue—systemic scleroderma	0.000351	0.0229	CbGeAlD
Ramipril—ACE—digestive system—systemic scleroderma	0.000277	0.0181	CbGeAlD
Ramipril—BCHE—smooth muscle tissue—systemic scleroderma	0.000259	0.0169	CbGeAlD
Ramipril—BCHE—skin of body—systemic scleroderma	0.000256	0.0167	CbGeAlD
Ramipril—Fosinopril—ACE—systemic scleroderma	0.000237	0.135	CrCbGaD
Ramipril—ACE—lung—systemic scleroderma	0.000231	0.0151	CbGeAlD
Ramipril—BCHE—digestive system—systemic scleroderma	0.000205	0.0134	CbGeAlD
Ramipril—SLC15A2—lung—systemic scleroderma	0.000202	0.0132	CbGeAlD
Ramipril—Perindopril—ACE—systemic scleroderma	0.000194	0.11	CrCbGaD
Ramipril—Spirapril—ACE—systemic scleroderma	0.000191	0.109	CrCbGaD
Ramipril—Moexipril—ACE—systemic scleroderma	0.000183	0.104	CrCbGaD
Ramipril—BCHE—lung—systemic scleroderma	0.000171	0.0112	CbGeAlD
Ramipril—Quinapril—ACE—systemic scleroderma	0.000171	0.0971	CrCbGaD
Ramipril—Cilazapril—ACE—systemic scleroderma	0.000171	0.0971	CrCbGaD
Ramipril—Lisinopril—ACE—systemic scleroderma	0.000171	0.0971	CrCbGaD
Ramipril—Trandolapril—ACE—systemic scleroderma	0.000165	0.0941	CrCbGaD
Ramipril—Benazepril—ACE—systemic scleroderma	0.000148	0.0845	CrCbGaD
Ramipril—Enalapril—ACE—systemic scleroderma	0.000125	0.0713	CrCbGaD
Ramipril—Erectile dysfunction—Prednisone—systemic scleroderma	3.36e-05	0.000616	CcSEcCtD
Ramipril—Leukopenia—Mycophenolate mofetil—systemic scleroderma	3.35e-05	0.000615	CcSEcCtD
Ramipril—Feeling abnormal—Leflunomide—systemic scleroderma	3.35e-05	0.000614	CcSEcCtD
Ramipril—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	3.34e-05	0.000614	CcSEcCtD
Ramipril—Fatigue—Mycophenolic acid—systemic scleroderma	3.34e-05	0.000613	CcSEcCtD
Ramipril—Nausea—Mometasone—systemic scleroderma	3.33e-05	0.000612	CcSEcCtD
Ramipril—Anorexia—Lisinopril—systemic scleroderma	3.33e-05	0.00061	CcSEcCtD
Ramipril—Gastrointestinal pain—Leflunomide—systemic scleroderma	3.32e-05	0.000609	CcSEcCtD
Ramipril—Weight increased—Prednisone—systemic scleroderma	3.32e-05	0.000609	CcSEcCtD
Ramipril—Constipation—Mycophenolic acid—systemic scleroderma	3.31e-05	0.000608	CcSEcCtD
Ramipril—Palpitations—Mycophenolate mofetil—systemic scleroderma	3.31e-05	0.000608	CcSEcCtD
Ramipril—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	3.29e-05	0.000604	CcSEcCtD
Ramipril—Cough—Mycophenolate mofetil—systemic scleroderma	3.27e-05	0.0006	CcSEcCtD
Ramipril—Hypotension—Lisinopril—systemic scleroderma	3.26e-05	0.000598	CcSEcCtD
Ramipril—Dizziness—Captopril—systemic scleroderma	3.26e-05	0.000598	CcSEcCtD
Ramipril—Liver function test abnormal—Methotrexate—systemic scleroderma	3.25e-05	0.000597	CcSEcCtD
Ramipril—Convulsion—Mycophenolate mofetil—systemic scleroderma	3.25e-05	0.000596	CcSEcCtD
Ramipril—Urticaria—Leflunomide—systemic scleroderma	3.23e-05	0.000592	CcSEcCtD
Ramipril—Abdominal pain—Leflunomide—systemic scleroderma	3.21e-05	0.000589	CcSEcCtD
Ramipril—Body temperature increased—Leflunomide—systemic scleroderma	3.21e-05	0.000589	CcSEcCtD
Ramipril—Acute coronary syndrome—Prednisone—systemic scleroderma	3.2e-05	0.000588	CcSEcCtD
Ramipril—Feeling abnormal—Mycophenolic acid—systemic scleroderma	3.19e-05	0.000586	CcSEcCtD
Ramipril—Chest pain—Mycophenolate mofetil—systemic scleroderma	3.19e-05	0.000585	CcSEcCtD
Ramipril—Myalgia—Mycophenolate mofetil—systemic scleroderma	3.19e-05	0.000585	CcSEcCtD
Ramipril—Arthralgia—Mycophenolate mofetil—systemic scleroderma	3.19e-05	0.000585	CcSEcCtD
Ramipril—Neuropathy peripheral—Prednisone—systemic scleroderma	3.18e-05	0.000585	CcSEcCtD
Ramipril—Myocardial infarction—Prednisone—systemic scleroderma	3.18e-05	0.000585	CcSEcCtD
Ramipril—Breast disorder—Methotrexate—systemic scleroderma	3.18e-05	0.000584	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	3.18e-05	0.000583	CcSEcCtD
Ramipril—Anxiety—Mycophenolate mofetil—systemic scleroderma	3.18e-05	0.000583	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	3.17e-05	0.000582	CcSEcCtD
Ramipril—Hypersensitivity—Azathioprine—systemic scleroderma	3.17e-05	0.000581	CcSEcCtD
Ramipril—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	3.17e-05	0.000581	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	3.17e-05	0.000581	CcSEcCtD
Ramipril—Insomnia—Lisinopril—systemic scleroderma	3.16e-05	0.000579	CcSEcCtD
Ramipril—Discomfort—Mycophenolate mofetil—systemic scleroderma	3.15e-05	0.000578	CcSEcCtD
Ramipril—Paraesthesia—Lisinopril—systemic scleroderma	3.13e-05	0.000575	CcSEcCtD
Ramipril—Vomiting—Captopril—systemic scleroderma	3.13e-05	0.000575	CcSEcCtD
Ramipril—Dry mouth—Mycophenolate mofetil—systemic scleroderma	3.12e-05	0.000572	CcSEcCtD
Ramipril—Dyspnoea—Lisinopril—systemic scleroderma	3.11e-05	0.000571	CcSEcCtD
Ramipril—Rash—Captopril—systemic scleroderma	3.11e-05	0.00057	CcSEcCtD
Ramipril—Dermatitis—Captopril—systemic scleroderma	3.1e-05	0.00057	CcSEcCtD
Ramipril—Somnolence—Lisinopril—systemic scleroderma	3.1e-05	0.000569	CcSEcCtD
Ramipril—Headache—Captopril—systemic scleroderma	3.09e-05	0.000567	CcSEcCtD
Ramipril—Confusional state—Mycophenolate mofetil—systemic scleroderma	3.08e-05	0.000566	CcSEcCtD
Ramipril—Dyspepsia—Lisinopril—systemic scleroderma	3.07e-05	0.000564	CcSEcCtD
Ramipril—Body temperature increased—Mycophenolic acid—systemic scleroderma	3.06e-05	0.000562	CcSEcCtD
Ramipril—Abdominal pain—Mycophenolic acid—systemic scleroderma	3.06e-05	0.000562	CcSEcCtD
Ramipril—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	3.06e-05	0.000561	CcSEcCtD
Ramipril—Oedema—Mycophenolate mofetil—systemic scleroderma	3.06e-05	0.000561	CcSEcCtD
Ramipril—Asthma—Methotrexate—systemic scleroderma	3.05e-05	0.000559	CcSEcCtD
Ramipril—Decreased appetite—Lisinopril—systemic scleroderma	3.03e-05	0.000557	CcSEcCtD
Ramipril—Eosinophilia—Methotrexate—systemic scleroderma	3.01e-05	0.000553	CcSEcCtD
Ramipril—Gastrointestinal disorder—Lisinopril—systemic scleroderma	3.01e-05	0.000553	CcSEcCtD
Ramipril—Fatigue—Lisinopril—systemic scleroderma	3.01e-05	0.000552	CcSEcCtD
Ramipril—Shock—Mycophenolate mofetil—systemic scleroderma	3.01e-05	0.000552	CcSEcCtD
Ramipril—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	3e-05	0.00055	CcSEcCtD
Ramipril—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	2.99e-05	0.000549	CcSEcCtD
Ramipril—Hypersensitivity—Leflunomide—systemic scleroderma	2.99e-05	0.000549	CcSEcCtD
Ramipril—Pancreatitis—Methotrexate—systemic scleroderma	2.99e-05	0.000548	CcSEcCtD
Ramipril—Constipation—Lisinopril—systemic scleroderma	2.98e-05	0.000548	CcSEcCtD
Ramipril—Tachycardia—Mycophenolate mofetil—systemic scleroderma	2.98e-05	0.000548	CcSEcCtD
Ramipril—Skin disorder—Mycophenolate mofetil—systemic scleroderma	2.97e-05	0.000545	CcSEcCtD
Ramipril—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	2.96e-05	0.000542	CcSEcCtD
Ramipril—Diarrhoea—Azathioprine—systemic scleroderma	2.94e-05	0.00054	CcSEcCtD
Ramipril—Nausea—Captopril—systemic scleroderma	2.93e-05	0.000537	CcSEcCtD
Ramipril—Abdominal discomfort—Methotrexate—systemic scleroderma	2.92e-05	0.000536	CcSEcCtD
Ramipril—Anorexia—Mycophenolate mofetil—systemic scleroderma	2.91e-05	0.000535	CcSEcCtD
Ramipril—Asthenia—Leflunomide—systemic scleroderma	2.91e-05	0.000535	CcSEcCtD
Ramipril—Pancytopenia—Methotrexate—systemic scleroderma	2.89e-05	0.000531	CcSEcCtD
Ramipril—Feeling abnormal—Lisinopril—systemic scleroderma	2.87e-05	0.000528	CcSEcCtD
Ramipril—Pruritus—Leflunomide—systemic scleroderma	2.87e-05	0.000527	CcSEcCtD
Ramipril—Connective tissue disorder—Prednisone—systemic scleroderma	2.87e-05	0.000526	CcSEcCtD
Ramipril—Hypotension—Mycophenolate mofetil—systemic scleroderma	2.86e-05	0.000524	CcSEcCtD
Ramipril—Gastrointestinal pain—Lisinopril—systemic scleroderma	2.85e-05	0.000524	CcSEcCtD
Ramipril—Neutropenia—Methotrexate—systemic scleroderma	2.85e-05	0.000523	CcSEcCtD
Ramipril—Dizziness—Azathioprine—systemic scleroderma	2.84e-05	0.000522	CcSEcCtD
Ramipril—Upper respiratory tract infection—Methotrexate—systemic scleroderma	2.83e-05	0.00052	CcSEcCtD
Ramipril—Erectile dysfunction—Methotrexate—systemic scleroderma	2.8e-05	0.000515	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	2.78e-05	0.000511	CcSEcCtD
Ramipril—Photosensitivity reaction—Methotrexate—systemic scleroderma	2.78e-05	0.00051	CcSEcCtD
Ramipril—Asthenia—Mycophenolic acid—systemic scleroderma	2.78e-05	0.00051	CcSEcCtD
Ramipril—Diarrhoea—Leflunomide—systemic scleroderma	2.78e-05	0.00051	CcSEcCtD
Ramipril—Urticaria—Lisinopril—systemic scleroderma	2.77e-05	0.000509	CcSEcCtD
Ramipril—Insomnia—Mycophenolate mofetil—systemic scleroderma	2.76e-05	0.000508	CcSEcCtD
Ramipril—Abdominal pain—Lisinopril—systemic scleroderma	2.76e-05	0.000506	CcSEcCtD
Ramipril—Body temperature increased—Lisinopril—systemic scleroderma	2.76e-05	0.000506	CcSEcCtD
Ramipril—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	2.74e-05	0.000504	CcSEcCtD
Ramipril—Pruritus—Mycophenolic acid—systemic scleroderma	2.74e-05	0.000503	CcSEcCtD
Ramipril—Vomiting—Azathioprine—systemic scleroderma	2.73e-05	0.000502	CcSEcCtD
Ramipril—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	2.73e-05	0.0005	CcSEcCtD
Ramipril—Somnolence—Mycophenolate mofetil—systemic scleroderma	2.72e-05	0.000499	CcSEcCtD
Ramipril—Rash—Azathioprine—systemic scleroderma	2.71e-05	0.000498	CcSEcCtD
Ramipril—Dermatitis—Azathioprine—systemic scleroderma	2.71e-05	0.000497	CcSEcCtD
Ramipril—Flushing—Prednisone—systemic scleroderma	2.71e-05	0.000497	CcSEcCtD
Ramipril—Headache—Azathioprine—systemic scleroderma	2.69e-05	0.000494	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	2.69e-05	0.000494	CcSEcCtD
Ramipril—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	2.69e-05	0.000494	CcSEcCtD
Ramipril—Dizziness—Leflunomide—systemic scleroderma	2.68e-05	0.000493	CcSEcCtD
Ramipril—Renal failure—Methotrexate—systemic scleroderma	2.67e-05	0.00049	CcSEcCtD
Ramipril—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	2.66e-05	0.000488	CcSEcCtD
Ramipril—Diarrhoea—Mycophenolic acid—systemic scleroderma	2.65e-05	0.000486	CcSEcCtD
Ramipril—Stomatitis—Methotrexate—systemic scleroderma	2.65e-05	0.000486	CcSEcCtD
Ramipril—Conjunctivitis—Methotrexate—systemic scleroderma	2.64e-05	0.000484	CcSEcCtD
Ramipril—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	2.64e-05	0.000484	CcSEcCtD
Ramipril—Immune system disorder—Prednisone—systemic scleroderma	2.63e-05	0.000484	CcSEcCtD
Ramipril—Constipation—Mycophenolate mofetil—systemic scleroderma	2.61e-05	0.00048	CcSEcCtD
Ramipril—Arrhythmia—Prednisone—systemic scleroderma	2.61e-05	0.000478	CcSEcCtD
Ramipril—Sweating—Methotrexate—systemic scleroderma	2.6e-05	0.000478	CcSEcCtD
Ramipril—Vomiting—Leflunomide—systemic scleroderma	2.58e-05	0.000474	CcSEcCtD
Ramipril—Alopecia—Prednisone—systemic scleroderma	2.58e-05	0.000473	CcSEcCtD
Ramipril—Hypersensitivity—Lisinopril—systemic scleroderma	2.57e-05	0.000472	CcSEcCtD
Ramipril—Hepatobiliary disease—Methotrexate—systemic scleroderma	2.57e-05	0.000471	CcSEcCtD
Ramipril—Dizziness—Mycophenolic acid—systemic scleroderma	2.56e-05	0.00047	CcSEcCtD
Ramipril—Epistaxis—Methotrexate—systemic scleroderma	2.56e-05	0.00047	CcSEcCtD
Ramipril—Rash—Leflunomide—systemic scleroderma	2.56e-05	0.00047	CcSEcCtD
Ramipril—Dermatitis—Leflunomide—systemic scleroderma	2.56e-05	0.000469	CcSEcCtD
Ramipril—Mental disorder—Prednisone—systemic scleroderma	2.56e-05	0.000469	CcSEcCtD
Ramipril—Nausea—Azathioprine—systemic scleroderma	2.55e-05	0.000469	CcSEcCtD
Ramipril—Headache—Leflunomide—systemic scleroderma	2.54e-05	0.000467	CcSEcCtD
Ramipril—Erythema—Prednisone—systemic scleroderma	2.54e-05	0.000466	CcSEcCtD
Ramipril—Malnutrition—Prednisone—systemic scleroderma	2.54e-05	0.000466	CcSEcCtD
Ramipril—Agranulocytosis—Methotrexate—systemic scleroderma	2.53e-05	0.000465	CcSEcCtD
Ramipril—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	2.52e-05	0.000462	CcSEcCtD
Ramipril—Asthenia—Lisinopril—systemic scleroderma	2.5e-05	0.000459	CcSEcCtD
Ramipril—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	2.5e-05	0.000459	CcSEcCtD
Ramipril—Pruritus—Lisinopril—systemic scleroderma	2.47e-05	0.000453	CcSEcCtD
Ramipril—Vomiting—Mycophenolic acid—systemic scleroderma	2.46e-05	0.000452	CcSEcCtD
Ramipril—Rash—Mycophenolic acid—systemic scleroderma	2.44e-05	0.000448	CcSEcCtD
Ramipril—Dermatitis—Mycophenolic acid—systemic scleroderma	2.44e-05	0.000448	CcSEcCtD
Ramipril—Hepatitis—Methotrexate—systemic scleroderma	2.44e-05	0.000447	CcSEcCtD
Ramipril—Urticaria—Mycophenolate mofetil—systemic scleroderma	2.43e-05	0.000446	CcSEcCtD
Ramipril—Headache—Mycophenolic acid—systemic scleroderma	2.43e-05	0.000445	CcSEcCtD
Ramipril—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	2.42e-05	0.000444	CcSEcCtD
Ramipril—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	2.42e-05	0.000444	CcSEcCtD
Ramipril—Nausea—Leflunomide—systemic scleroderma	2.41e-05	0.000443	CcSEcCtD
Ramipril—Diarrhoea—Lisinopril—systemic scleroderma	2.39e-05	0.000438	CcSEcCtD
Ramipril—Ill-defined disorder—Prednisone—systemic scleroderma	2.36e-05	0.000432	CcSEcCtD
Ramipril—Visual impairment—Methotrexate—systemic scleroderma	2.35e-05	0.000431	CcSEcCtD
Ramipril—Agitation—Prednisone—systemic scleroderma	2.33e-05	0.000428	CcSEcCtD
Ramipril—Angioedema—Prednisone—systemic scleroderma	2.32e-05	0.000426	CcSEcCtD
Ramipril—Dizziness—Lisinopril—systemic scleroderma	2.31e-05	0.000423	CcSEcCtD
Ramipril—Erythema multiforme—Methotrexate—systemic scleroderma	2.3e-05	0.000423	CcSEcCtD
Ramipril—Nausea—Mycophenolic acid—systemic scleroderma	2.3e-05	0.000422	CcSEcCtD
Ramipril—Malaise—Prednisone—systemic scleroderma	2.29e-05	0.00042	CcSEcCtD
Ramipril—Vertigo—Prednisone—systemic scleroderma	2.28e-05	0.000419	CcSEcCtD
Ramipril—Syncope—Prednisone—systemic scleroderma	2.28e-05	0.000418	CcSEcCtD
Ramipril—Tinnitus—Methotrexate—systemic scleroderma	2.27e-05	0.000417	CcSEcCtD
Ramipril—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	2.25e-05	0.000413	CcSEcCtD
Ramipril—Loss of consciousness—Prednisone—systemic scleroderma	2.23e-05	0.00041	CcSEcCtD
Ramipril—Vomiting—Lisinopril—systemic scleroderma	2.22e-05	0.000407	CcSEcCtD
Ramipril—Immune system disorder—Methotrexate—systemic scleroderma	2.2e-05	0.000404	CcSEcCtD
Ramipril—Rash—Lisinopril—systemic scleroderma	2.2e-05	0.000404	CcSEcCtD
Ramipril—Convulsion—Prednisone—systemic scleroderma	2.2e-05	0.000404	CcSEcCtD
Ramipril—Dermatitis—Lisinopril—systemic scleroderma	2.2e-05	0.000403	CcSEcCtD
Ramipril—Mediastinal disorder—Methotrexate—systemic scleroderma	2.2e-05	0.000403	CcSEcCtD
Ramipril—Asthenia—Mycophenolate mofetil—systemic scleroderma	2.19e-05	0.000403	CcSEcCtD
Ramipril—Headache—Lisinopril—systemic scleroderma	2.19e-05	0.000401	CcSEcCtD
Ramipril—Pruritus—Mycophenolate mofetil—systemic scleroderma	2.16e-05	0.000397	CcSEcCtD
Ramipril—Arthralgia—Prednisone—systemic scleroderma	2.16e-05	0.000397	CcSEcCtD
Ramipril—Myalgia—Prednisone—systemic scleroderma	2.16e-05	0.000397	CcSEcCtD
Ramipril—Anxiety—Prednisone—systemic scleroderma	2.15e-05	0.000395	CcSEcCtD
Ramipril—Alopecia—Methotrexate—systemic scleroderma	2.15e-05	0.000395	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	2.15e-05	0.000394	CcSEcCtD
Ramipril—Discomfort—Prednisone—systemic scleroderma	2.14e-05	0.000392	CcSEcCtD
Ramipril—Mental disorder—Methotrexate—systemic scleroderma	2.14e-05	0.000392	CcSEcCtD
Ramipril—Malnutrition—Methotrexate—systemic scleroderma	2.12e-05	0.000389	CcSEcCtD
Ramipril—Erythema—Methotrexate—systemic scleroderma	2.12e-05	0.000389	CcSEcCtD
Ramipril—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	2.09e-05	0.000384	CcSEcCtD
Ramipril—Dysgeusia—Methotrexate—systemic scleroderma	2.08e-05	0.000381	CcSEcCtD
Ramipril—Nausea—Lisinopril—systemic scleroderma	2.07e-05	0.00038	CcSEcCtD
Ramipril—Oedema—Prednisone—systemic scleroderma	2.07e-05	0.00038	CcSEcCtD
Ramipril—Anaphylactic shock—Prednisone—systemic scleroderma	2.07e-05	0.00038	CcSEcCtD
Ramipril—Shock—Prednisone—systemic scleroderma	2.04e-05	0.000374	CcSEcCtD
Ramipril—Nervous system disorder—Prednisone—systemic scleroderma	2.03e-05	0.000373	CcSEcCtD
Ramipril—Tachycardia—Prednisone—systemic scleroderma	2.02e-05	0.000371	CcSEcCtD
Ramipril—Dizziness—Mycophenolate mofetil—systemic scleroderma	2.02e-05	0.000371	CcSEcCtD
Ramipril—Skin disorder—Prednisone—systemic scleroderma	2.01e-05	0.000369	CcSEcCtD
Ramipril—Hyperhidrosis—Prednisone—systemic scleroderma	2e-05	0.000368	CcSEcCtD
Ramipril—Anorexia—Prednisone—systemic scleroderma	1.98e-05	0.000363	CcSEcCtD
Ramipril—Ill-defined disorder—Methotrexate—systemic scleroderma	1.97e-05	0.000361	CcSEcCtD
Ramipril—Vomiting—Mycophenolate mofetil—systemic scleroderma	1.94e-05	0.000357	CcSEcCtD
Ramipril—Rash—Mycophenolate mofetil—systemic scleroderma	1.93e-05	0.000354	CcSEcCtD
Ramipril—Dermatitis—Mycophenolate mofetil—systemic scleroderma	1.93e-05	0.000353	CcSEcCtD
Ramipril—Headache—Mycophenolate mofetil—systemic scleroderma	1.91e-05	0.000352	CcSEcCtD
Ramipril—Malaise—Methotrexate—systemic scleroderma	1.91e-05	0.000351	CcSEcCtD
Ramipril—Vertigo—Methotrexate—systemic scleroderma	1.91e-05	0.00035	CcSEcCtD
Ramipril—Leukopenia—Methotrexate—systemic scleroderma	1.9e-05	0.000349	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Prednisone—systemic scleroderma	1.89e-05	0.000347	CcSEcCtD
Ramipril—Insomnia—Prednisone—systemic scleroderma	1.87e-05	0.000344	CcSEcCtD
Ramipril—Paraesthesia—Prednisone—systemic scleroderma	1.86e-05	0.000342	CcSEcCtD
Ramipril—Cough—Methotrexate—systemic scleroderma	1.85e-05	0.00034	CcSEcCtD
Ramipril—Convulsion—Methotrexate—systemic scleroderma	1.84e-05	0.000337	CcSEcCtD
Ramipril—Dyspepsia—Prednisone—systemic scleroderma	1.82e-05	0.000335	CcSEcCtD
Ramipril—Nausea—Mycophenolate mofetil—systemic scleroderma	1.82e-05	0.000333	CcSEcCtD
Ramipril—Myalgia—Methotrexate—systemic scleroderma	1.81e-05	0.000332	CcSEcCtD
Ramipril—Arthralgia—Methotrexate—systemic scleroderma	1.81e-05	0.000332	CcSEcCtD
Ramipril—Chest pain—Methotrexate—systemic scleroderma	1.81e-05	0.000332	CcSEcCtD
Ramipril—Decreased appetite—Prednisone—systemic scleroderma	1.8e-05	0.000331	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	1.79e-05	0.000329	CcSEcCtD
Ramipril—Fatigue—Prednisone—systemic scleroderma	1.79e-05	0.000328	CcSEcCtD
Ramipril—Discomfort—Methotrexate—systemic scleroderma	1.78e-05	0.000328	CcSEcCtD
Ramipril—Constipation—Prednisone—systemic scleroderma	1.77e-05	0.000325	CcSEcCtD
Ramipril—Confusional state—Methotrexate—systemic scleroderma	1.75e-05	0.000321	CcSEcCtD
Ramipril—Anaphylactic shock—Methotrexate—systemic scleroderma	1.73e-05	0.000318	CcSEcCtD
Ramipril—Feeling abnormal—Prednisone—systemic scleroderma	1.71e-05	0.000313	CcSEcCtD
Ramipril—Nervous system disorder—Methotrexate—systemic scleroderma	1.7e-05	0.000312	CcSEcCtD
Ramipril—Thrombocytopenia—Methotrexate—systemic scleroderma	1.7e-05	0.000311	CcSEcCtD
Ramipril—Gastrointestinal pain—Prednisone—systemic scleroderma	1.69e-05	0.000311	CcSEcCtD
Ramipril—Skin disorder—Methotrexate—systemic scleroderma	1.68e-05	0.000309	CcSEcCtD
Ramipril—Hyperhidrosis—Methotrexate—systemic scleroderma	1.67e-05	0.000307	CcSEcCtD
Ramipril—Anorexia—Methotrexate—systemic scleroderma	1.65e-05	0.000303	CcSEcCtD
Ramipril—Urticaria—Prednisone—systemic scleroderma	1.65e-05	0.000302	CcSEcCtD
Ramipril—Abdominal pain—Prednisone—systemic scleroderma	1.64e-05	0.000301	CcSEcCtD
Ramipril—Body temperature increased—Prednisone—systemic scleroderma	1.64e-05	0.000301	CcSEcCtD
Ramipril—Hypotension—Methotrexate—systemic scleroderma	1.62e-05	0.000297	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	1.58e-05	0.00029	CcSEcCtD
Ramipril—Insomnia—Methotrexate—systemic scleroderma	1.57e-05	0.000288	CcSEcCtD
Ramipril—Paraesthesia—Methotrexate—systemic scleroderma	1.55e-05	0.000285	CcSEcCtD
Ramipril—Dyspnoea—Methotrexate—systemic scleroderma	1.54e-05	0.000283	CcSEcCtD
Ramipril—Somnolence—Methotrexate—systemic scleroderma	1.54e-05	0.000283	CcSEcCtD
Ramipril—Hypersensitivity—Prednisone—systemic scleroderma	1.53e-05	0.00028	CcSEcCtD
Ramipril—Dyspepsia—Methotrexate—systemic scleroderma	1.52e-05	0.00028	CcSEcCtD
Ramipril—Decreased appetite—Methotrexate—systemic scleroderma	1.51e-05	0.000276	CcSEcCtD
Ramipril—Gastrointestinal disorder—Methotrexate—systemic scleroderma	1.49e-05	0.000274	CcSEcCtD
Ramipril—Fatigue—Methotrexate—systemic scleroderma	1.49e-05	0.000274	CcSEcCtD
Ramipril—Asthenia—Prednisone—systemic scleroderma	1.49e-05	0.000273	CcSEcCtD
Ramipril—Pruritus—Prednisone—systemic scleroderma	1.47e-05	0.000269	CcSEcCtD
Ramipril—Feeling abnormal—Methotrexate—systemic scleroderma	1.43e-05	0.000262	CcSEcCtD
Ramipril—Diarrhoea—Prednisone—systemic scleroderma	1.42e-05	0.00026	CcSEcCtD
Ramipril—Gastrointestinal pain—Methotrexate—systemic scleroderma	1.42e-05	0.00026	CcSEcCtD
Ramipril—Urticaria—Methotrexate—systemic scleroderma	1.38e-05	0.000253	CcSEcCtD
Ramipril—Dizziness—Prednisone—systemic scleroderma	1.37e-05	0.000252	CcSEcCtD
Ramipril—Body temperature increased—Methotrexate—systemic scleroderma	1.37e-05	0.000251	CcSEcCtD
Ramipril—Abdominal pain—Methotrexate—systemic scleroderma	1.37e-05	0.000251	CcSEcCtD
Ramipril—Vomiting—Prednisone—systemic scleroderma	1.32e-05	0.000242	CcSEcCtD
Ramipril—Rash—Prednisone—systemic scleroderma	1.31e-05	0.00024	CcSEcCtD
Ramipril—Dermatitis—Prednisone—systemic scleroderma	1.31e-05	0.00024	CcSEcCtD
Ramipril—Headache—Prednisone—systemic scleroderma	1.3e-05	0.000238	CcSEcCtD
Ramipril—Hypersensitivity—Methotrexate—systemic scleroderma	1.28e-05	0.000234	CcSEcCtD
Ramipril—Asthenia—Methotrexate—systemic scleroderma	1.24e-05	0.000228	CcSEcCtD
Ramipril—Nausea—Prednisone—systemic scleroderma	1.23e-05	0.000226	CcSEcCtD
Ramipril—Pruritus—Methotrexate—systemic scleroderma	1.23e-05	0.000225	CcSEcCtD
Ramipril—Diarrhoea—Methotrexate—systemic scleroderma	1.18e-05	0.000217	CcSEcCtD
Ramipril—Dizziness—Methotrexate—systemic scleroderma	1.15e-05	0.00021	CcSEcCtD
Ramipril—Vomiting—Methotrexate—systemic scleroderma	1.1e-05	0.000202	CcSEcCtD
Ramipril—Rash—Methotrexate—systemic scleroderma	1.09e-05	0.0002	CcSEcCtD
Ramipril—Dermatitis—Methotrexate—systemic scleroderma	1.09e-05	0.0002	CcSEcCtD
Ramipril—Headache—Methotrexate—systemic scleroderma	1.08e-05	0.000199	CcSEcCtD
Ramipril—Nausea—Methotrexate—systemic scleroderma	1.03e-05	0.000189	CcSEcCtD
